# Eplus Inc: overview

PLUS · Nasdaq · CIK 1022408 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/plus.md) · [Financials](/companies/plus/financials.md) · [Filings](/companies/plus/filings.md) · [Insiders](/companies/plus/insiders.md)

Latest reported revenue: [$649.1m](/filings/0001140361-26-031274.md) for Q1 FY2027, three months to 2026-06-30, from the 10-Q filed Aug 4, 2026 (XBRL us-gaap:Revenues, accession 0001140361-26-031274).

## Last eight quarters

| Line item | Unit | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [493](/filings/0001140361-25-040814.md) | [493](/filings/0001140361-26-003725.md) | [478 d](/filings/0001140361-26-023171.md) | [643](/filings/0001140361-26-031274.md) | [609](/filings/0001140361-25-040814.md) | [615](/filings/0001140361-26-003725.md) | [582 d](/filings/0001140361-26-023171.md) | [649](/filings/0001140361-26-031274.md) |
| Gross margin | % | [25.8%](/filings/0001140361-25-040814.md) | [25.4%](/filings/0001140361-26-003725.md) | [27.8% d](/filings/0001140361-26-023171.md) | [23.9%](/filings/0001140361-26-031274.md) | [26.6%](/filings/0001140361-25-040814.md) | [25.8%](/filings/0001140361-26-003725.md) | [25.3% d](/filings/0001140361-26-023171.md) | [23.3%](/filings/0001140361-26-031274.md) |
| Operating margin | % | [5.5%](/filings/0001140361-25-040814.md) | [3.3%](/filings/0001140361-26-003725.md) | [5.2% d](/filings/0001140361-26-023171.md) | [6.7%](/filings/0001140361-26-031274.md) | [8.0%](/filings/0001140361-25-040814.md) | [7.1%](/filings/0001140361-26-003725.md) | [6.5% d](/filings/0001140361-26-023171.md) | [6.0%](/filings/0001140361-26-031274.md) |
| Net margin | % | [6.3%](/filings/0001140361-26-003725.md) | [4.9%](/filings/0001140361-26-003725.md) | [4.6% d](/filings/0001140361-26-023171.md) | [6.6%](/filings/0001140361-26-031274.md) | [5.7%](/filings/0001140361-26-003725.md) | [5.7%](/filings/0001140361-26-003725.md) | [4.3% d](/filings/0001140361-26-023171.md) | [4.7%](/filings/0001140361-26-031274.md) |
| Diluted EPS | $ per share | [1.17](/filings/0001140361-25-040814.md) | [0.91](/filings/0001140361-26-003725.md) | not reported | [1.61](/filings/0001140361-26-031274.md) | [1.32](/filings/0001140361-25-040814.md) | [1.33](/filings/0001140361-26-003725.md) | not reported | [1.16](/filings/0001140361-26-031274.md) |
| Free cash flow | $m | not reported | not reported | [159 d](/filings/0001140361-26-023171.md) | [(99.8)](/filings/0001140361-26-031274.md) | not reported | not reported | [104 d](/filings/0001140361-26-023171.md) | [75.6](/filings/0001140361-26-031274.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure.

## Last five fiscal years

| Line item | Unit | FY2022 (2022-03-31) | FY2023 (2023-03-31) | FY2024 (2024-03-31) | FY2025 (2025-03-31) | FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,821](/filings/0001140361-24-027200.md) | [2,068](/filings/0001140361-25-020204.md) | [2,178](/filings/0001140361-26-023171.md) | [2,000](/filings/0001140361-26-023171.md) | [2,443](/filings/0001140361-26-023171.md) |
| Gross margin | % | [25.3%](/filings/0001140361-24-027200.md) | [25.0%](/filings/0001140361-25-020204.md) | [23.5%](/filings/0001140361-26-023171.md) | [25.6%](/filings/0001140361-26-023171.md) | [25.2%](/filings/0001140361-26-023171.md) |
| Operating margin | % | [8.1%](/filings/0001140361-24-027200.md) | [8.0%](/filings/0001140361-25-020204.md) | [6.1%](/filings/0001140361-26-023171.md) | [5.0%](/filings/0001140361-26-023171.md) | [6.8%](/filings/0001140361-26-023171.md) |
| Net margin | % | [5.8%](/filings/0001140361-24-027200.md) | [5.8%](/filings/0001140361-25-020204.md) | [5.4%](/filings/0001140361-26-023171.md) | [5.2%](/filings/0001140361-26-023171.md) | [5.4%](/filings/0001140361-26-023171.md) |
| Diluted EPS | $ per share | [3.93](/filings/0001140361-24-027200.md) | [4.48](/filings/0001140361-25-020204.md) | [4.41](/filings/0001140361-26-023171.md) | [3.93](/filings/0001140361-26-023171.md) | [5.03](/filings/0001140361-26-023171.md) |
| Free cash flow | $m | not reported | not reported | [241](/filings/0001140361-26-023171.md) | [297](/filings/0001140361-26-023171.md) | [(121)](/filings/0001140361-26-023171.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/plus/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $337.9m | 4,060,186 |  | Added +56,745 |
| [River Road Asset Management, LLC](/funds/1341401.md) | 2026-06-30 | $131.7m | 1,582,148 |  | Reduced −42,524 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $113.9m | 1,368,044 |  | Added +57,666 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $96.6m | 1,160,310 |  | Reduced −5,598 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $95.1m | 1,142,862 |  | Added +42,415 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $88.8m | 1,066,916 |  | Added +53,187 |
| [FIRST TRUST ADVISORS LP](/funds/1125816.md) | 2026-06-30 | $76.6m | 920,085 |  | Added +341,038 |
| [AltraVue Capital, LLC](/funds/1740837.md) | 2026-06-30 | $75.8m | 910,893 |  | Reduced −15,760 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $65.9m | 791,462 |  | Added +26,165 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $63.1m | 758,251 |  | Reduced −217,958 |

## Recent filings

[All 1,339 filings](/companies/plus/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-14 | 21:13 ET | [8-K](/filings/0001022408-26-000084.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001022408-26-000084 |
| 2026-08-04 | 21:29 ET | [8-K](/filings/0001140361-26-031282.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-031282 |
| 2026-08-04 | 21:16 ET | [10-Q](/filings/0001140361-26-031274.md) | Quarterly report, period 2026-06-30 | 0001140361-26-031274 |
| 2026-07-24 | 20:02 ET | [DEF 14A](/filings/0001140361-26-029593.md) | Proxy statement, period 2026-09-10 | 0001140361-26-029593 |
| 2026-07-06 | 20:41 ET | [8-K](/filings/0001022408-26-000064.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001022408-26-000064 |
| 2026-05-28 | 21:02 ET | [10-K](/filings/0001140361-26-023171.md) | Annual report, period 2026-03-31 | 0001140361-26-023171 |
| 2026-05-28 | 20:25 ET | [8-K](/filings/0001140361-26-023148.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-023148 |
| 2026-02-17 | 21:35 ET | [8-K](/filings/0001022408-26-000021.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001022408-26-000021 |
| 2026-02-04 | 22:06 ET | [10-Q](/filings/0001140361-26-003725.md) | Quarterly report, period 2025-12-31 | 0001140361-26-003725 |
| 2026-02-04 | 21:31 ET | [8-K](/filings/0001022408-26-000017.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001022408-26-000017 |

## Latest annual report

[Form 10-K for the fiscal year ended Mar 31, 2026](/filings/0001140361-26-023171.md), filed May 28, 2026.

## Forecast league

Q2 FY2027, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/36acff20-bc29-419c-8e50-469a559e48d9)

## About the filer

- CIK: 1022408
- Tickers: PLUS
- Exchange: Nasdaq
- SIC code: 5045 Wholesale-Computers & Peripheral Equipment & Software
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.